C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2006
12/28/2006	US20060292668 Nuclear factor of activated t cell receptor
12/28/2006	US20060292648 Screening for target that disrupts interaction between human osteopontin (OPN) and an alpha 4 integrin; inflammatory diseases
12/28/2006	US20060292644 Novel tumor-associated marker
12/28/2006	US20060292643 Recognition molecules for the treatment and detection of tumours
12/28/2006	US20060292638 Sequence #115 as a target for identifying weight modulating compounds
12/28/2006	US20060292636 Quantum (TM) phytase; high sensitivity and specificity for the phytase and are useful in immunoassay methods; capable of detecting low concentrations of phytase
12/28/2006	US20060292627 PB39, a gene dysregulated in prostate cancer, and uses thereof
12/28/2006	US20060292625 Novel human leucine-rich repeat domain containing protein HLLRCR-1
12/28/2006	US20060292598 Nucleotide sequences coding mitogenic racemase for use diagnostic probe in detection and prevention of parasite infection; immunotherapy
12/28/2006	US20060292593 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
12/28/2006	US20060292591 Genes from the 20q13 amplicon and their uses
12/28/2006	US20060292573 Human orthologues of WART
12/28/2006	US20060292556 Method of detecting antibodies to HCV
12/28/2006	US20060292548 Using channel protein and immobilized nerve to identify inhibitors of bitter and/or sweet taste preception
12/28/2006	US20060292180 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide
12/28/2006	US20060292161 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections
12/28/2006	US20060292160 Specifically reacts with HIV-infected cells and induces apoptosis to the infected cells to lead the cells to destruction; immunoglobulins
12/28/2006	US20060292157 MDA-7 protein variants having antiproliferative activity
12/28/2006	US20060292154 A34 and a33-Like 3dna, proteins, antibodies thereto and methods of treatment using same
12/28/2006	US20060292153 Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders
12/28/2006	US20060292152 used for the for the medical diagnosis and treatment of Alzheimer's disease
12/28/2006	US20060292150 Methods of using wisp antagonists
12/28/2006	US20060292149 antihemophilic factor monoclonal antibodies comprising an immunoglobulin heavy chain and light chain amino acid sequences, with modified by enzymatic deglycosylation or by site directed mutagenesis, used for treating hemostasis disorders; anticoagulants
12/28/2006	US20060292148 Antihuman TNF-alpha antibody activity lowering inhibitor
12/28/2006	US20060292147 Blood MMP-3 level-lowering agent comprising IL-6 antagonist as active ingredient
12/28/2006	US20060292146 Isolated PTPMT1 protein which mediates insulin production and uses thereof
12/28/2006	US20060292145 Human antihuman interleukin-18 antibody, fragment thereof and method for using same
12/28/2006	US20060292144 Human disintegrin protein
12/28/2006	US20060292143 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
12/28/2006	US20060292142 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
12/28/2006	US20060292140 Humanized immunoglobulin reactive with alpha4beta7 integrin
12/28/2006	US20060292139 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence
12/28/2006	US20060292138 Fusion proteins comprising an allergen sequence linked via an IgG hinge region to another polypeptide sequence capable of specifically binding to a native IgG inhibitory receptor containing an immune receptor tyrosine based inhibitory motif
12/28/2006	US20060292116 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders
12/28/2006	US20060292074 Tomoregulin antibodies and uses thereof
12/28/2006	CA2680945A1 Anti-pdgfralpha antibodies
12/28/2006	CA2612941A1 Method for the potentiation of opioid analgesics effects on pain
12/28/2006	CA2612417A1 Anti-gfralpha3 antibodies
12/28/2006	CA2612355A1 Antibody complexes
12/28/2006	CA2612302A1 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis
12/28/2006	CA2612240A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae
12/28/2006	CA2612021A1 Compositions and methods for treating and diagnosing cancer
12/28/2006	CA2611924A1 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
12/28/2006	CA2611816A1 Methods of purifying fc region containing proteins
12/28/2006	CA2611815A1 Methods of purifying anti a beta antibodies
12/28/2006	CA2611149A1 Anti-igf1r antibody formulations
12/28/2006	CA2608278A1 Immunogenic compositions for chlamydia trachomatis
12/28/2006	CA2606084A1 Improved method of treating degenerative spinal disorders
12/27/2006	EP1736547A1 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation
12/27/2006	EP1736545A2 Soluble zcytor 11 cytokine receptors
12/27/2006	EP1736484A1 An gene enginf; ering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody
12/27/2006	EP1736172A1 Method of utilizing organic cation transporter oct3-related molecule for treating mental diseases such as depression, anxiety neurosis, drug addiction and the like
12/27/2006	EP1736163A1 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
12/27/2006	EP1736162A1 Remedy for prion disease and method of producing the same
12/27/2006	EP1735463A2 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators in non-small cell lung cancer
12/27/2006	EP1735445A2 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
12/27/2006	EP1735432A1 Cancerous disease modifying antibodies
12/27/2006	EP1735350A2 Anti-cea scfv - beta-lactamase constructs (cab molecules) in adept
12/27/2006	EP1735349A2 Phosphorylcholine conjugates and corresponding antibodies
12/27/2006	EP1735348A1 Human anti-epidermal growth factor receptor antibody
12/27/2006	EP1735347A2 Specific binding members against synaptophysin
12/27/2006	EP1735334A1 Set1 proteins and uses therefor
12/27/2006	EP1735000A2 Method for augmenting b cell depletion
12/27/2006	EP1734998A2 Compositions and methods comprising an egfl7 antagonist for modulating vascular development
12/27/2006	EP1734997A2 Steroid sparing agents and methods of using same
12/27/2006	EP1734996A2 Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
12/27/2006	EP1734995A1 Monoclonal antibodies to hepatocyte growth factor
12/27/2006	EP1734986A1 Method for modulating appetite
12/27/2006	EP1373500B1 Gene involved in v(d)j recombination and/or dna repair
12/27/2006	EP1354047B1 Methods for screening compounds that modulate lipid metabolism
12/27/2006	EP1326974B1 Methods of using a human il-17-related polypeptide to treat disease
12/27/2006	EP1303602B1 Soluble zalpha11 cytokine receptors
12/27/2006	EP1297147B1 Compositions for the diagnosis and treatment of herpes simplex virus infection
12/27/2006	EP1242401B1 Cytotoxic agents comprising taxanes and their therapeutic use
12/27/2006	EP1183362B1 Il-1 eta dna and polypeptides
12/27/2006	EP1117437B1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
12/27/2006	EP1084252B1 Nucleic acid vaccines for prevention of flavivirus infection
12/27/2006	EP1073739B1 Cd40-interacting and traf-interacting proteins
12/27/2006	EP1000088B1 Process for the separation of specific immunoglobulins from standard plasma
12/27/2006	EP0973804B1 Anti-vegf antibodies
12/27/2006	CN1886426A Antibodies that bind interleukin-4 receptor
12/27/2006	CN1886425A Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens traditionally of low immunogenicity
12/27/2006	CN1886424A Anti-IGF-I receptor antibody
12/27/2006	CN1886423A Glycoisoforms of adiponectin and uses thereof
12/27/2006	CN1886158A Pharmaceutical preparation comprising an antibody against the EGF receptor
12/27/2006	CN1886155A Isolated mammalian membrane protein genes and related reagents
12/27/2006	CN1886118A Solid forms of anti-EGFR-antibodies.
12/27/2006	CN1884535A Anti human CD19 mouse immune globulin variable zone gene and uses
12/27/2006	CN1884505A Tumour related protein kinase RX17 and its uses
12/27/2006	CN1884303A SARS-CoV virus structural protein infusion protein and its high yield expression and purification and uses
12/27/2006	CN1292069C HIV-1 virus tat-protein mutants
12/27/2006	CN1291757C Remedy for inflammatory bowel diseases
12/27/2006	CN1291756C Blood cell production via activation of hemeglobin scavenger receptor
12/26/2006	US7154026 Arabidopsis lyases for modulating starch and polysaccharide concentration in plant cells and organs; antisense agents
12/26/2006	US7153955 Apparatus for use as diagnostic and therapeutic tool in gene therapy
12/26/2006	US7153944 High affinity integrin polypeptides and uses thereof
12/26/2006	US7153941 Antibodies that bind PRO4994 polypeptides
12/26/2006	US7153940 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
12/26/2006	US7153939 PRO354 antibodies
12/26/2006	US7153936 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity

1 ... 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 ... 1494